Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,898,200 | 3,419,300 | 3,675,600 | 2,646,600 | 1,749,300 |
| Marketable Securities | 2,143,100 | 1,473,500 | 1,235,500 | 2,151,300 | 2,002,400 |
| Receivables | 1,634,400 | 1,705,000 | 1,568,800 | 1,567,600 | 1,632,000 |
| Inventories | 1,281,000 | 1,344,400 | 1,375,000 | 1,294,200 | 1,215,400 |
| Other current assets | 1,805,800 | 1,849,000 | 1,910,900 | 2,081,200 | 1,316,800 |
| TOTAL | $9,762,500 | $9,791,200 | $9,765,800 | $9,740,900 | $7,915,900 |
| Non-Current Assets | |||||
| PPE Net | 3,300,900 | 3,298,600 | 3,266,400 | 3,355,100 | 3,372,800 |
| Investments And Advances | 2,359,000 | 2,234,900 | 2,472,900 | 2,603,700 | 2,769,100 |
| Intangibles | 7,565,100 | 7,599,100 | 7,750,100 | 7,824,900 | 7,908,800 |
| Other Non-Current Assets | 1,610,900 | 1,630,300 | 1,599,000 | 1,556,800 | 1,647,800 |
| TOTAL | $14,835,900 | $14,762,900 | $15,088,400 | $15,340,500 | $15,698,500 |
| Total Assets | $24,598,400 | $24,554,100 | $24,854,200 | $25,081,400 | $23,614,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 491,200 | 491,500 | 383,200 | 434,800 | 398,700 |
| Accrued Expenses | 2,288,200 | 2,521,400 | 3,305,900 | 3,298,500 | 2,231,100 |
| TOTAL | $3,014,900 | $3,272,800 | $3,926,400 | $5,018,000 | $3,946,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,282,700 | 6,281,000 | 6,279,200 | 6,277,400 | 6,275,700 |
| Other Non-Current Liabilities | 1,262,800 | 1,278,100 | 1,552,700 | 1,441,300 | 1,685,501 |
| TOTAL | $7,796,500 | $7,892,900 | $8,161,000 | $8,200,000 | $8,447,101 |
| Total Liabilities | $10,811,400 | $11,165,700 | $12,087,400 | $13,218,000 | $12,393,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 144,742 | 144,486 | 144,001 | 145,113 | 146,452 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 16,854,400 | 16,466,500 | 15,916,100 | 14,959,900 | 14,215,500 |
| Other shareholders' equity | -181,700 | -174,500 | -172,400 | -119,600 | -136,900 |
| TOTAL | $13,787,000 | $13,388,400 | $12,766,800 | $11,863,400 | $11,220,700 |
| Total Liabilities And Equity | $24,598,400 | $24,554,100 | $24,854,200 | $25,081,400 | $23,614,400 |